The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Psychotherapy, Group

 Edworthy,  Dobkin,  Clarke,  Da Costa,  Dritsa,  Fortin,  Barr,  Ensworth,  Esdaile,  Beaulieu,  Zummer,  Senécal,  Goulet,  Choquette,  Rich,  Smith,  Cividino,  Gladman,  Devins,  Fagan,  Wise,  Schmidt,  Berlin,  Davey,  Murphy,  Graziano,  Boswell,  Pavia,  Cancio,  Nadler,  Chaitt,  Dewar,  Sahner,  Duliege,  Capra,  Leong,  Giedlin,  Lane,  Kahn,  Gisbert,  Khorrami,  Carballo,  Calvet,  Gene,  Dominguez-Muñoz,  Kastrati,  von Beckerath,  Joost,  Pogatsa-Murray,  Gorchakova,  Schömig,  Heimberg,  Liebowitz,  Hope,  Schneier,  Holt,  Welkowitz,  Juster,  Campeas,  Bruch,  Cloitre,  Fallon,  Klein,  Sayin,  Varol,  Balkanli-Kaplan,  Sayin,  Furmark,  Tillfors,  Marteinsdottir,  Fischer,  Pissiota,  Långström,  Fredrikson,  Gama de Abreu,  Wilmink,  Hübler,  Koch,  Masuda,  Nakazato,  Kihara,  Minagoe,  Tei,  de Wit,  Herrstedt,  Rapoport,  Carides,  Guoguang-Ma,  Elmer,  Schmidt,  Evans,  Horgan,  Esplen,  Hunter,  Leszcz,  Warner,  Narod,  Metcalfe,  Glendon,  Butler,  Liede,  Young,  Kieffer,  DiProspero,  Irwin,  Wong,  Suzuki,  Kanno,  Anand,  Yusuf,  Pogue,  Weitz,  Flather,  Lincoff,  Califf,  Van de Werf,  Willerson,  White,  Armstrong,  Guetta,  Gibler,  Hochman,  Bode,  Vahanian,  Steg,  Ardissino,  Savonitto,  Bar,  Sadowski,  Betriu,  Booth,  Wolski,  Waller,  Topol,  George,  Ziedonis,  Feingold,  Pepper,  Satterburg,  Winkel,  Rounsaville,  Kosten,  Davidson,  Foa,  Huppert,  Keefe,  Franklin,  Compton,  Zhao,  Connor,  Lynch,  Gadde,  Lord,  Mack,  Van Den Berg,  Pike,  Ingles,  Haiman,  Wang,  Parisky,  Hodis,  Ursin,  Misri,  Reebye,  Corral,  Milis,  
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Psychotherapy, Group


Psychiatry related information on Psychotherapy, Group


High impact information on Psychotherapy, Group

  • The overall rate of response (both remission and satisfactory response) was 48 percent in both the nefazodone group and in the psychotherapy group, as compared with 73 percent in the combined-treatment group [11].
  • Reinfarction within the first 7 days occurred in 3.5% of patients in the reteplase group and 2.3% of patients in the combination therapy group, and was significantly associated with 1-year mortality (22.6% in patients with reinfarction vs 8.0% in patients without reinfarction; HR, 3.08; 95% CI, 2.53-3.75; P<.001) [12].
  • Common treatment methods are cognitive-behavioral, group therapy, and, when appropriate, medications such as androgen-lowering agents that can act as sexual appetite suppressants [13].
  • Both groups had mean (SD) increases in CD4 cell percentage: from 20.4% (6.3%) to 32.3% (12.4%) for the combination therapy group compared with 20.4% (5.1%) to 23.0% (7.2%) for recipients of ART alone (P<.001) [14].
  • In response to estrogen suppression, plasma levels of FSH, LH, and prolactin did not change significantly throughout the treatment period in either therapy group [15].

Chemical compound and disease context of Psychotherapy, Group


Biological context of Psychotherapy, Group


Anatomical context of Psychotherapy, Group

  • Of 90 patients in the combined therapy group, most received a preoperative intracavitary insertion (3500 mgh to the uterus and 2000 mgh to the upper vagina) and preoperative external beam pelvic irradiation (2000 cGy whole pelvis, additional 3000 cGy to parametria, with midline shield) followed in 4 to 6 weeks by a TAH-BSO [26].
  • METHODOLOGY: Seven of 18 patients received hepatic arterial infusion (HAI) of lymphokine-activated killer (LAK) cells with or without IL-2 against metastatic liver tumors (local therapy group) [27].
  • Twenty C5 through C7 spinal cord injury individuals recruited from a University outpatient clinic were randomly assigned to a massage therapy group or an exercise group [28].
  • The basal levels of PGE2 concentration and acid secretion in gastric juice did not differ significantly between the steroid therapy group and control group [29].

Gene context of Psychotherapy, Group


Analytical, diagnostic and therapeutic context of Psychotherapy, Group


  1. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. Perrillo, R.P., Schiff, E.R., Davis, G.L., Bodenheimer, H.C., Lindsay, K., Payne, J., Dienstag, J.L., O'Brien, C., Tamburro, C., Jacobson, I.M. N. Engl. J. Med. (1990) [Pubmed]
  2. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results. Anand, S.S., Yusuf, S., Pogue, J., Weitz, J.I., Flather, M. Circulation (1998) [Pubmed]
  3. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. Phillips, G.L., Wolff, S.N., Fay, J.W., Herzig, R.H., Lazarus, H.M., Schold, C., Herzig, G.P. J. Clin. Oncol. (1986) [Pubmed]
  4. Octreotide as primary therapy for acromegaly. Newman, C.B., Melmed, S., George, A., Torigian, D., Duhaney, M., Snyder, P., Young, W., Klibanski, A., Molitch, M.E., Gagel, R., Sheeler, L., Cook, D., Malarkey, W., Jackson, I., Vance, M.L., Barkan, A., Frohman, L., Kleinberg, D.L. J. Clin. Endocrinol. Metab. (1998) [Pubmed]
  5. Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial. Ferraccioli, G.F., Assaloni, R., Di Poi, E., Gremese, E., De Marchi, G., Fabris, M. Rheumatology (Oxford, England) (2002) [Pubmed]
  6. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Heimberg, R.G., Liebowitz, M.R., Hope, D.A., Schneier, F.R., Holt, C.S., Welkowitz, L.A., Juster, H.R., Campeas, R., Bruch, M.A., Cloitre, M., Fallon, B., Klein, D.F. Arch. Gen. Psychiatry (1998) [Pubmed]
  7. Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Shea, M.T., Elkin, I., Imber, S.D., Sotsky, S.M., Watkins, J.T., Collins, J.F., Pilkonis, P.A., Beckham, E., Glass, D.R., Dolan, R.T. Arch. Gen. Psychiatry (1992) [Pubmed]
  8. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. George, T.P., Ziedonis, D.M., Feingold, A., Pepper, W.T., Satterburg, C.A., Winkel, J., Rounsaville, B.J., Kosten, T.R. The American journal of psychiatry. (2000) [Pubmed]
  9. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. Misri, S., Reebye, P., Corral, M., Milis, L. The Journal of clinical psychiatry. (2004) [Pubmed]
  10. Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus. Edworthy, S.M., Dobkin, P.L., Clarke, A.E., Da Costa, D., Dritsa, M., Fortin, P.R., Barr, S., Ensworth, S., Esdaile, J.M., Beaulieu, A., Zummer, M., Senécal, J.L., Goulet, J.R., Choquette, D., Rich, E., Smith, D., Cividino, A., Gladman, D., Devins, G.M. J. Rheumatol. (2003) [Pubmed]
  11. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. Keller, M.B., McCullough, J.P., Klein, D.N., Arnow, B., Dunner, D.L., Gelenberg, A.J., Markowitz, J.C., Nemeroff, C.B., Russell, J.M., Thase, M.E., Trivedi, M.H., Zajecka, J. N. Engl. J. Med. (2000) [Pubmed]
  12. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. Lincoff, A.M., Califf, R.M., Van de Werf, F., Willerson, J.T., White, H.D., Armstrong, P.W., Guetta, V., Gibler, W.B., Hochman, J.S., Bode, C., Vahanian, A., Steg, P.G., Ardissino, D., Savonitto, S., Bar, F., Sadowski, Z., Betriu, A., Booth, J.E., Wolski, K., Waller, M., Topol, E.J. JAMA (2002) [Pubmed]
  13. Pedophilia. Fagan, P.J., Wise, T.N., Schmidt, C.W., Berlin, F.S. JAMA (2002) [Pubmed]
  14. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. Davey, R.T., Murphy, R.L., Graziano, F.M., Boswell, S.L., Pavia, A.T., Cancio, M., Nadler, J.P., Chaitt, D.G., Dewar, R.L., Sahner, D.K., Duliege, A.M., Capra, W.B., Leong, W.P., Giedlin, M.A., Lane, H.C., Kahn, J.O. JAMA (2000) [Pubmed]
  15. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma. Samojlik, E., Veldhuis, J.D., Wells, S.A., Santen, R.J. J. Clin. Invest. (1980) [Pubmed]
  16. The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group. McHutchison, J.G., Poynard, T., Pianko, S., Gordon, S.C., Reid, A.E., Dienstag, J., Morgan, T., Yao, R., Albrecht, J. Gastroenterology (2000) [Pubmed]
  17. Imipramine as treatment for depression in addicts. Kleber, H.D., Weissman, M.M., Rounsaville, B.J., Wilber, C.H., Prusoff, B.A., Riordan, C.E. Arch. Gen. Psychiatry (1983) [Pubmed]
  18. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Davidson, J.R., Foa, E.B., Huppert, J.D., Keefe, F.J., Franklin, M.E., Compton, J.S., Zhao, N., Connor, K.M., Lynch, T.R., Gadde, K.M. Arch. Gen. Psychiatry (2004) [Pubmed]
  19. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Bruns, F.J., Adler, S., Fraley, D.S., Segel, D.P. Ann. Intern. Med. (1991) [Pubmed]
  20. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Gourley, M.F., Austin, H.A., Scott, D., Yarboro, C.H., Vaughan, E.M., Muir, J., Boumpas, D.T., Klippel, J.H., Balow, J.E., Steinberg, A.D. Ann. Intern. Med. (1996) [Pubmed]
  21. Vaporized perfluorohexane attenuates ventilator-induced lung injury in isolated, perfused rabbit lungs. Gama de Abreu, M., Wilmink, B., Hübler, M., Koch, T. Anesthesiology (2005) [Pubmed]
  22. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients. Suzuki, H., Kanno, Y. Hypertens. Res. (2005) [Pubmed]
  23. Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor. Sayin, N.C., Varol, F.G., Balkanli-Kaplan, P., Sayin, M. Journal of perinatal medicine. (2004) [Pubmed]
  24. Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy. Kastrati, A., von Beckerath, N., Joost, A., Pogatsa-Murray, G., Gorchakova, O., Schömig, A. Circulation (2004) [Pubmed]
  25. Repeated thermal therapy diminishes appetite loss and subjective complaints in mildly depressed patients. Masuda, A., Nakazato, M., Kihara, T., Minagoe, S., Tei, C. Psychosomatic medicine. (2005) [Pubmed]
  26. Stage II carcinoma of the endometrium: results of therapy and prognostic factors. Grigsby, P.W., Perez, C.A., Camel, H.M., Kao, M.S., Galakatos, A.E. Int. J. Radiat. Oncol. Biol. Phys. (1985) [Pubmed]
  27. Clinical application of adoptive immunotherapy and IL-2 for the treatment of advanced digestive tract cancer. Ueda, Y., Yamagishi, H., Tanioka, Y., Fujiwara, H., Fuji, N., Itoh, T., Fujiki, H., Yoshimura, T., Oka, T. Hepatogastroenterology (1999) [Pubmed]
  28. Spinal cord patients benefit from massage therapy. Diego, M.A., Field, T., Hernandez-Reif, M., Hart, S., Brucker, B., Field, T., Burman, I. Int. J. Neurosci. (2002) [Pubmed]
  29. Impaired increase of prostaglandin E2 in gastric juice during steroid therapy in children. Shimizu, T., Yamashiro, Y., Yabuta, K. Journal of paediatrics and child health. (1994) [Pubmed]
  30. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study. Lord, S.J., Mack, W.J., Van Den Berg, D., Pike, M.C., Ingles, S.A., Haiman, C.A., Wang, W., Parisky, Y.R., Hodis, H.N., Ursin, G. Breast Cancer Res. (2005) [Pubmed]
  31. Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock. Staudinger, T., Presterl, E., Graninger, W., Locker, G.J., Knapp, S., Laczika, K., Klappacher, G., Stoiser, B., Wagner, A., Tesinsky, P., Kordova, H., Frass, M. Intensive care medicine. (1996) [Pubmed]
  32. Combination therapy with interferon alpha and beta to chronic hepatitis C. Horiike, N., Hino, H., Tanaka, Y., Miyaoka, H., Miki, S., Yamashita, S., Matsuura, B., Kubo, Y., Ikeda, Y., Akbar, S.M., Masumoto, T., Michitaka, K., Onji, M. Oncol. Rep. (2003) [Pubmed]
  33. A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Esplen, M.J., Hunter, J., Leszcz, M., Warner, E., Narod, S., Metcalfe, K., Glendon, G., Butler, K., Liede, A., Young, M.A., Kieffer, S., DiProspero, L., Irwin, E., Wong, J. Cancer (2004) [Pubmed]
  34. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Furmark, T., Tillfors, M., Marteinsdottir, I., Fischer, H., Pissiota, A., Långström, B., Fredrikson, M. Arch. Gen. Psychiatry (2002) [Pubmed]
  35. Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate. Seiler, C., Suter, T.M., Hess, O.M. J. Am. Coll. Cardiol. (1995) [Pubmed]
  36. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials. de Wit, R., Herrstedt, J., Rapoport, B., Carides, A.D., Guoguang-Ma, J., Elmer, M., Schmidt, C., Evans, J.K., Horgan, K.J. Eur. J. Cancer (2004) [Pubmed]
  37. Pharmacokinetics and nephrotoxicity of continuous intravenous infusion of gentamicin in low birth weight infants. Giacoia, G.P., Schentag, J.J. J. Pediatr. (1986) [Pubmed]
  38. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Gisbert, J.P., Khorrami, S., Carballo, F., Calvet, X., Gene, E., Dominguez-Muñoz, E. Aliment. Pharmacol. Ther. (2004) [Pubmed]
WikiGenes - Universities